Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT01845818
Eligibility Criteria:
Inclusion Criteria:
* Patient \>= 18 years and \<= 50 years
* Patient diagnosed with AS or PsA
* Patient to be initiated on adalimumab (according to the Marketing Authorization and Belgian reimbursement criteria)
* Patient willing to sign informed consent
Exclusion Criteria:
* Any contraindication for adalimumab as specified in the corresponding Summary of Product Characteristics (SmPC)
* Patient previously treated with biologics
* Patient participating in other AbbVie-sponsored trials
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT01845818
Study Brief:
Protocol Section:
NCT01845818